Thomas Ichim

Thomas E.
Ichim is the founder of Batu Biologics, Inc., founded in 2014, serving as President, Chief Executive Officer & Director.
Dr. Ichim is the founder of Tolerotech, Inc., founded in 2002, serving as Vice President-Business Development.
Dr. Ichim was the founder of MedVax Pharma Corp., founded in 2003, serving as Chief Executive Officer from 2003 to 2005.
Dr. Ichim was the founder of Biorasi LLC, founded in 2004, serving as Program Manager from 2004 to 2007.
Dr. Ichim was the founder of Oncomune LLC, founded in 2006, serving as Chief Technology Officer from 2006 to 2009.
Current jobs include Director at Therapeutic Solutions International, Inc. since 2016; Director & President-Biotech Division at Creative Medical Health, Inc. since 2011; President & Director at Creative Medical Technologies, Inc. since 2016; Managing Partner at Vendevia Group since 2004; Research Associate at Society of Clinical Research Associates since 2005; and Chief Scientific Officer & President at Immorta Bio, Inc. Former jobs include Chief Executive Officer at Emvolio, Inc.; President, Director & Chief Scientific Officer at Medistem, Inc. from 2013 to 2015; Director & Chief Scientific Officer at Regen Biopharma, Inc. from 2012 to 2015; Director at Riordan Clinic Inc; Director & Chief Scientific Officer at Creative Medical Technology Holdings, Inc. from 2017 to 2021; Director & Chief Scientific Officer at Nobilis Therapeutics, Inc.; Director-Regulatory Affairs at MarrowTech Pharma, Inc. from 2000 to 2003; Director at Carbon Manna UC from 2010 to 2011; Vice President-Cellular Therapies at Precigen, Inc.; and President at Batu Centre For Leukemia Research from 1995 to 1997.
Education includes an undergraduate degree from The University of Waterloo conferred in 1998, a graduate degree from the University of Western Ontario conferred in 2003, and a doctorate from the University of Science, Arts & Technology conferred in 2007.